The precipitous drop in funding from the Global Fund to Fight AIDS, TB and malaria can be a “fatal blow” to the progress made so far, reported the humanitarian organization Doctors Without Borders (MSF).
The organization called attention to the fact that, for example, had never been so close to controlling the AIDS epidemic, which is now in the air for this decline in funding.
This situation has been reached both by the economic crisis in some donor countries, for its impact on the credibility of the institution discovered embezzlement in four African countries and other mismanagement.
For MSF, the decision “threatens the historic progress achieved in the fight against AIDS and tuberculosis” in particular and the possibility that 15 million patients receive treatment in 2015, a commitment made by the Global Fund with the support of donors.
Progress in combating AIDS is managed by a combination of political will, translated into economic-contributions, advances in medicine and boost the production of generic drugs.
In the field, the change in attitudes has also been radical decentralization increasing patient care through participation and delegation of tasks in communities, allowing more people benefit from treatment, MSF said.
Also, try to time to people infected with HIV avoided overloading the health facilities (limited in itself) and decreased the transmission of this virus.
As for drugs, had access to better treatments, such as tenofovir-based, less toxic and easier to administer, facilitating the daily care to patients.
All this, according to MSF, is in danger, as seen in “Malawi, Lesotho and Uganda, where the start is delayed under treatment,” while “the DRC treatment is rationed.”
In this country of 71 million people and where it is estimated that more than one million infected with AIDS virus, only 2 000 patients started treatment during 2011, five times less than the previous year.
Meanwhile, coverage of ART among those who need it remains below 15%, said the humanitarian organization.
For tuberculosis, MSF mentioned the case of Burma, where we know that there will be a lack of treatment for multidrug-resistant version (multiple-drug) of this disease, while of the 9 000 300 new cases diagnosed each year, only three percent is treated.
With this scenario, the NGO said that the lack of financial resources beyond 2014 will jeopardize the possibility that patients receive care.